Charting Our Journey

We recently attended ISPOR Europe 2024 in Barcelona, Spain.

We recently attended Global Evidence Summit (GES) in Prague.

Fostering collaboration and innovation. Our recent team offsite provided a valuable opportunity to strengthen connections, share ideas, and align on our goals for the future.

At ISPOR in Atlanta, Georgia, we presented three posters on the following topics:

• Use of Large Language Models (LLMs) for Full-Text Screening in Systematic Literature
• Real-World Effectiveness and Safety of First-Line Pembrolizumab Monotherapy for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis,
• Mapping the Current Clinical Landscape for Alzheimer’s Disease: A Qualitative Analysis.

It was a great opportunity to engage with fellow HEOR professionals and share insights on the latest advancements in the field.

We had the opportunity to present two posters at the 2023 ISPOR conference in Copenhagen, Denmark. Our two posters covered exciting advancements:

• Budget Impact Analysis of the Endo Arteriovenous Fistula System (WavelinQ) for creating hemodialysis access in patients with end-stage kidney disease
• Comparative Analysis of Large Language Models (#LLM) used in Systematic Literature Reviews.

For more information, you can view both posters in the ‘Resources’ section of our website.

Our team connected for a fun offsite.

We presented five posters at International Society for Pharmacoeconomics & Outcomes Research (ISPOR) 2022 conference held at Vienna, Austria.

Our posters could be viewed from ‘Resources’ section of our website.

Organized by
Department of Pharmacology, Pondicherry Institute of Medical Sciences, Puducherry
In association with
Indian Medical Pharmacologists Association

About the workshop
Health economics is an application of economic theory, models and empirical techniques to the analysis of decision making by individuals, health care providers and governments with respect to health and health care. In simple terms, it attempts to find whether the added benefit of one intervention is worth the added cost of that intervention. We aim through this workshop to create awareness and stimulate health economics research.

Resource persons
Mr. Mahendra Rai, Head & SME, RWI solutions, IQVIA
Mr. Hemant Rathi, MD, Skyward Analytics
Dr. Malkeet Singh, Health Economist, HTAIn Secretariat, Dept. of Health Research, MoHFW, GOI

More details about the workshop is provided in attached document below:

Workshop brochure

We are delighted to share that our Director, Hemant Rathi, has been appointed as an Adjunct Faculty at the Department of Commerce, MAHE, Manipal for a period of two years.

Our Director Mr. Hemant Rathi presented on the topic of “Health Technology Assessment” at Nanyang Technological University (NTU), Singapore. This session was organised as part of ongoing course on Medical Device Regulatory Affairs

In the first year itself, we cemented our presence as a high-quality service provider serving clients in Australia, Singapore, UAE, UK and USA. From starting as an independent consultant, we also grew in size with health economists and systematic reviewer on board

Our company was formally incorporated on 31 August 2017 with a vision to provide quality data analytic services.